Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note
SHE
/
Balance Sheet
/
PP&E Net

Shedir Pharma Srl Unipersonale
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shedir Pharma Srl Unipersonale
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
PP&E Net
€7.8m
CAGR 3-Years
9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
PP&E Net
€342k
CAGR 3-Years
-19%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
PP&E Net
€183m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
8%
P
Pierrel SpA
MIL:PRL
PP&E Net
€37.1m
CAGR 3-Years
40%
CAGR 5-Years
30%
CAGR 10-Years
8%
Friulchem SpA
MIL:FCM
PP&E Net
€5.7m
CAGR 3-Years
50%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shedir Pharma Srl Unipersonale's PP&E Net?
PP&E Net
7.8m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's PP&E Net amounts to 7.8m EUR.

What is Shedir Pharma Srl Unipersonale's PP&E Net growth rate?
PP&E Net CAGR 5Y
-10%

Over the last year, the PP&E Net growth was 55%. The average annual PP&E Net growth rates for Shedir Pharma Srl Unipersonale have been 9% over the past three years , -10% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.